Hollsteen
← Arista

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: $850M · 10-Q 0001596532-16-000255 filed May 5, 2016Equity incl. NCI · Q2 2016: $917M · 10-Q 0001596532-16-000291 filed Aug 5, 2016Equity incl. NCI · Q3 2016: $1.0B · 10-Q 0001596532-16-000331 filed Nov 3, 2016Equity incl. NCI · Q4 2016: $1.1B · 10-K 0001596532-17-000019 filed Feb 17, 2017Equity incl. NCI · Q1 2017: $1.2B · 10-Q 0001596532-17-000088 filed May 8, 2017Equity incl. NCI · Q2 2017: $1.4B · 10-Q 0001596532-17-000201 filed Aug 4, 2017Equity incl. NCI · Q3 2017: $1.5B · 10-Q 0001596532-17-000251 filed Nov 3, 2017Equity incl. NCI · Q4 2017: $1.7B · 10-K 0001596532-18-000018 filed Feb 20, 2018Equity incl. NCI · Q1 2018: $1.8B · 10-Q 0001596532-18-000109 filed May 4, 2018Equity incl. NCI · Q2 2018: $1.7B · 10-Q 0001596532-18-000174 filed Aug 8, 2018Equity incl. NCI · Q3 2018: $1.9B · 10-Q 0001596532-18-000233 filed Nov 5, 2018Equity incl. NCI · Q4 2018: $2.1B · 10-K 0001596532-19-000027 filed Feb 15, 2019Equity incl. NCI · Q1 2019: $2.4B · 10-Q 0001596532-19-000104 filed May 6, 2019Equity incl. NCI · Q2 2019: $2.5B · 10-Q 0001596532-19-000184 filed Aug 2, 2019Equity incl. NCI · Q3 2019: $2.7B · 10-Q 0001596532-19-000230 filed Nov 1, 2019Equity incl. NCI · Q4 2019: $2.9B · 10-K 0001596532-20-000024 filed Feb 14, 2020Equity incl. NCI · Q1 2020: $2.8B · 10-Q 0001628280-20-006504 filed May 6, 2020Equity incl. NCI · Q2 2020: $3.0B · 10-Q 0001596532-20-000148 filed Aug 5, 2020Equity incl. NCI · Q3 2020: $3.1B · 10-Q 0001596532-20-000226 filed Nov 3, 2020Equity incl. NCI · Q4 2020: $3.3B · 10-K 0001596532-21-000049 filed Feb 19, 2021Equity incl. NCI · Q1 2021: $3.5B · 10-Q 0001596532-21-000149 filed May 6, 2021Equity incl. NCI · Q2 2021: $3.7B · 10-Q 0001596532-21-000255 filed Aug 3, 2021Equity incl. NCI · Q3 2021: $3.9B · 10-Q 0001596532-21-000354 filed Nov 2, 2021Equity incl. NCI · Q4 2021: $4.0B · 10-K 0001596532-22-000026 filed Feb 15, 2022Equity incl. NCI · Q1 2022: $4.2B · 10-Q 0001596532-22-000112 filed May 3, 2022Equity incl. NCI · Q2 2022: $4.0B · 10-Q 0001596532-22-000220 filed Aug 2, 2022Equity incl. NCI · Q3 2022: $4.4B · 10-Q 0001596532-22-000294 filed Nov 1, 2022Equity incl. NCI · Q4 2022: $4.9B · 10-K 0001596532-26-000013 filed Feb 17, 2026Equity incl. NCI · Q1 2023: $5.3B · 10-Q 0001596532-23-000104 filed May 2, 2023Equity incl. NCI · Q2 2023: $5.9B · 10-Q 0001596532-23-000197 filed Aug 1, 2023Equity incl. NCI · Q3 2023: $6.5B · 10-Q 0001596532-23-000274 filed Oct 31, 2023Equity incl. NCI · Q4 2023: $7.2B · 10-K 0001596532-24-000043 filed Feb 13, 2024Equity incl. NCI · Q1 2024: $7.9B · 10-Q 0001596532-25-000106 filed May 7, 2025Equity incl. NCI · Q2 2024: $8.4B · 10-Q 0001596532-25-000216 filed Aug 6, 2025Equity incl. NCI · Q3 2024: $9.2B · 10-Q 0001596532-25-000286 filed Nov 5, 2025Equity incl. NCI · Q4 2024: $10.0B · 10-K 0001596532-26-000013 filed Feb 17, 2026Equity incl. NCI · Q1 2025: $10.1B · 10-Q 0001596532-25-000106 filed May 7, 2025Equity incl. NCI · Q2 2025: $10.9B · 10-Q 0001596532-25-000216 filed Aug 6, 2025Equity incl. NCI · Q3 2025: $11.9B · 10-Q 0001596532-25-000286 filed Nov 5, 2025Equity incl. NCI · Q4 2025: $12.4B · 10-K 0001596532-26-000013 filed Feb 17, 2026Equity incl. NCI · Q1 2026: $13.5B · 10-Q 0001596532-26-000078 filed May 6, 2026Equity incl. NCI · Q2 2026: $14.8B · 10-Q 0001596532-26-000175 filed Aug 5, 20267.914.80.8Q1 2016Q2 2026Q1 2024
Q1 2024
7.9$B
All values (42)
PeriodValue ($B)Status
Q2 202614.8reported
Q1 202613.5reported
Q4 202512.4reported
Q3 202511.9reported
Q2 202510.9reported
Q1 202510.1reported
Q4 202410.0reported
Q3 20249.2reported
Q2 20248.4reported
Q1 20247.9reported
Q4 20237.2reported
Q3 20236.5reported
Q2 20235.9reported
Q1 20235.3reported
Q4 20224.9reported
Q3 20224.4reported
Q2 20224.0reported
Q1 20224.2reported
Q4 20214.0reported
Q3 20213.9reported
Q2 20213.7reported
Q1 20213.5reported
Q4 20203.3reported
Q3 20203.1reported
Q2 20203.0reported
Q1 20202.8reported
Q4 20192.9reported
Q3 20192.7reported
Q2 20192.5reported
Q1 20192.4reported
Q4 20182.1reported
Q3 20181.9reported
Q2 20181.7reported
Q1 20181.8reported
Q4 20171.7reported
Q3 20171.5reported
Q2 20171.4reported
Q1 20171.2reported
Q4 20161.1reported
Q3 20161.0reported
Q2 20160.9reported
Q1 20160.8reported

CSV with all sources · Technical ID: equity_total

More metrics for Arista
Sources & calculation
Value
$7.9B
Period
Q1 2024, ended Mar 31, 2024 · as of Mar 31, 2024 (balance as of date, not a sum)
Source
10-Q, filed May 7, 2025 · 0001596532-25-000106
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v2$7.9BMay 7, 202510-Q 0001596532-25-000106reported · confidence 1. · current
v1$7.9BMay 8, 202410-Q 0001596532-24-000173reported · confidence 1.